EMPIL–DOC Act

Expanding Medical Partnerships with Israel to Lessen Dependence on China Act or the EMPIL-DOC Act

This bill authorizes a bilateral grant program with Israel to develop health technologies, with an emphasis on the use of technology, personalized medicine, and data in relation to COVID-19 (i.e., coronavirus disease 2019). Technologies to be developed through this program include, among others, artificial intelligence, respiratory assist devices, and diagnostic tests.

In addition, the program conditions funding on a matching contribution from the government of Israel.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6829 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 6829

 To authorize funding for a bilateral cooperative program with Israel 
 for the development of health technologies with a focus on combating 
                               COVID-19.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 12, 2020

  Mr. Pappas (for himself, Mr. Gooden, Mr. Suozzi, and Mr. Kustoff of 
  Tennessee) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To authorize funding for a bilateral cooperative program with Israel 
 for the development of health technologies with a focus on combating 
                               COVID-19.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Expanding Medical Partnerships with 
Israel to Lessen Dependence on China Act'' or the ``EMPIL-DOC Act''.

SEC. 2. BILATERAL COOPERATIVE AGREEMENT.

    (a) Authorization of Appropriations.--There is authorized to be 
appropriated to the Secretary of Health and Human Services $4,000,000 
for each of fiscal years 2021 through 2023 for a bilateral cooperative 
program with the Government of Israel for awarding grants for the 
development of health technologies, including such technologies 
described in subsection (b), subject to subsection (c), with an 
emphasis on collaboratively advancing the use of technology, 
personalized medicine, and data in relation to COVID-19.
    (b) Types of Health Technologies.--The health technologies 
described in this subsection shall include technologies such as 
artificial intelligence, drugs and vaccinations, respiratory assist 
devices, diagnostic tests, and telemedicine.
    (c) Restrictions on Funding.--The funding under subsection (a) is 
subject to a matching contribution from the Government of Israel.
    (d) Option for Establishing New Program.--The amounts appropriated 
under subsection (a) may be--
            (1) for a bilateral program with the Government of Israel 
        that is in existence on the day before the date of enactment of 
        this Act for the purposes described in such subsection; or
            (2) for a bilateral program with the Government of Israel 
        that is established after the date of enactment of this Act by 
        the Secretary of Health and Human Services, in consultation 
        with the Secretary of State, in accordance with the Agreement 
        between the Government of the United States of America and the 
        Government of the State of Israel on Cooperation in Science and 
        Technology for Homeland Security Matters, done at Jerusalem May 
        29, 2008 (or a successor agreement), for the purposes described 
        in subsection (a).
                                 <all>